drugset / Trial / NCT03614923
Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
RandomizedParallel-groupTriple-blindTreatment
Summary
A study to evaluate the safety and efficacy of multiple doses of etokimab in adults with chronic rhinosinusitis with nasal polyps.
Timeline
- Start
- 2018-11-29
- Primary completion
- 2020-09-02
- Completion
- 2020-10-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etokimab | Monoclonal antibody | 150 mg | Subcutaneous |
| Background | Mometasone furoate | Other / unclassified | 200 ug | Intranasal |
| Background | Mometasone furoate | Other / unclassified | 400 ug | Intranasal |